Peter Hume Chapman sold $37M of IONQ
Executive Chair at IonQ, Inc.. 2,000,000 shares at an average of $18.72, traded Mar 11, 2025, filed Mar 11, 2025.
Score components
- +20RoleChair
- +25Trade size$37.4M at market
- +20Share of holdings soldSold 83% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +38.4%, 3m +112.5%, 6m +135.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-007746, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 11, 2025 | MOption exercise Common Stock | +1,528,394 | $0.13 | $199k | 1,942,757 | Mar 11, 2025 |
| Mar 11, 2025 | MOption exercise Common Stock | +471,606 | $7.63 | $3.6M | 2,414,363 | Mar 11, 2025 |
| Mar 11, 2025 | SOpen-market sale Common Stock | -2,000,000 | $18.72 | $37M | 414,363 | Mar 11, 2025 |
| Mar 11, 2025 | MOption exercise Stock Option (right to buy)derivative | -1,528,394 | $0.00 | $0 | 6,568,511 | Mar 11, 2025 |
| Mar 11, 2025 | MOption exercise Stock Option (right to buy)derivative | -471,606 | $0.00 | $0 | 235,334 | Mar 11, 2025 |
Related signals
Other insiders at IonQ, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 4Weak | IonQ, Inc. | John w Raymond director, other | $90k 2,407 shares | -3% | |
| 21Weak | IonQ, Inc. | Kathryn K. Chou director | $152k 2,757 shares | -4% | |
| 22Weak | IonQ, Inc. | John w Raymond director, other | $210k 3,815 shares | -5% | |
| 26Weak | IonQ, Inc. | Gabrielle B Toledano director | $152k 2,757 shares | -20% | |
| 0Weak | IonQ, Inc. | Robert T. Cardillo director, other | $188k 3,773 shares | -3% | |
| 0Weak | IonQ, Inc. | Robert T. Cardillo director, other | $112k 2,500 shares | -2% | |
| 33Weak | IonQ, Inc. | John w Raymond director, other | $93k 2,800 shares | -3% | |
| 7Weak | IonQ, Inc. | Robert T. Cardillo director, other | $204k 5,165 shares | -4% | |
| 39Weak | IONQbuy IonQ, Inc. | William J Teuber Jr director | $115k 3,000 shares | +47% | |
| 3Weak | IonQ, Inc. | Gabrielle B Toledano director | $19k 616 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.